CN Patent

CN100360538C — 噻吩并嘧啶化合物及其用途

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2008-01-09 · 18y expired

What this patent protects

本发明披露具有下述通式的化合物或其盐：式中R 1 为C 1-4 烷基；R 2 为(1)取代或未取代的5-至7-元含氮的杂环基，取代基选自：(1’)卤素，(2’)羟基，(3’)C 1-4 烷基和(4’)C 1-4 烷氧基；(2)任选具有取代基的苯基，取代基选自：(1’)卤素，(2’)C 1-4 烷氧基-C 1-4 烷基，(3’)单-C 1-4 烷基-氨基甲酰基-C 1-4 烷基，(4’)C 1-4 烷氧基和(5’)单-C 1-4 烷基氨基甲酰基-C 1-4 烷氧基等；R 3 为C 1-4 烷基；R 4 为C 1-4 烷氧基等；n为1-4的整数；所述化合物为…

USPTO Abstract

本发明披露具有下述通式的化合物或其盐：式中R 1 为C 1-4 烷基；R 2 为(1)取代或未取代的5-至7-元含氮的杂环基，取代基选自：(1’)卤素，(2’)羟基，(3’)C 1-4 烷基和(4’)C 1-4 烷氧基；(2)任选具有取代基的苯基，取代基选自：(1’)卤素，(2’)C 1-4 烷氧基-C 1-4 烷基，(3’)单-C 1-4 烷基-氨基甲酰基-C 1-4 烷基，(4’)C 1-4 烷氧基和(5’)单-C 1-4 烷基氨基甲酰基-C 1-4 烷氧基等；R 3 为C 1-4 烷基；R 4 为C 1-4 烷氧基等；n为1-4的整数；所述化合物为具有促性腺素释放激素拮抗活性的噻吩并嘧啶化合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN100360538C
Jurisdiction
CN
Classification
—
Expires
2008-01-09
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.